Plexus (NASDAQ:PLXS – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.
A number of other research firms have also recently commented on PLXS. Needham & Company LLC upped their target price on Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Benchmark upped their price objective on Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Williams Trading set a $195.00 target price on Plexus in a research report on Wednesday, January 28th. Stifel Nicolaus upped their price target on shares of Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a report on Friday, January 30th. Finally, Weiss Ratings downgraded shares of Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, February 20th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $189.20.
View Our Latest Stock Analysis on PLXS
Plexus Trading Down 2.4%
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.07 billion. During the same period in the previous year, the company earned $1.73 EPS. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, analysts anticipate that Plexus will post 5.9 earnings per share for the current year.
Insider Buying and Selling at Plexus
In other Plexus news, COO Oliver K. Mihm sold 9,541 shares of the firm’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total transaction of $1,921,557.40. Following the transaction, the chief operating officer owned 12,809 shares of the company’s stock, valued at approximately $2,579,732.60. This trade represents a 42.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Angelo Michael Ninivaggi, Jr. sold 4,303 shares of the business’s stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $203.06, for a total transaction of $873,767.18. Following the completion of the sale, the chief accounting officer owned 20,099 shares of the company’s stock, valued at approximately $4,081,302.94. This represents a 17.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 47,495 shares of company stock worth $9,620,681. Insiders own 1.78% of the company’s stock.
Hedge Funds Weigh In On Plexus
Institutional investors have recently bought and sold shares of the business. American Century Companies Inc. lifted its holdings in Plexus by 44.2% during the third quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after buying an additional 338,119 shares during the period. Victory Capital Management Inc. raised its position in shares of Plexus by 130.0% in the 4th quarter. Victory Capital Management Inc. now owns 349,057 shares of the technology company’s stock worth $51,311,000 after acquiring an additional 197,283 shares in the last quarter. MetLife Investment Management LLC lifted its stake in shares of Plexus by 713.3% during the 4th quarter. MetLife Investment Management LLC now owns 126,971 shares of the technology company’s stock worth $18,665,000 after purchasing an additional 111,360 shares during the last quarter. Balyasny Asset Management L.P. purchased a new stake in shares of Plexus during the 3rd quarter worth $12,509,000. Finally, Arrowstreet Capital Limited Partnership boosted its position in Plexus by 965.0% during the third quarter. Arrowstreet Capital Limited Partnership now owns 80,890 shares of the technology company’s stock valued at $11,704,000 after purchasing an additional 73,295 shares in the last quarter. 94.45% of the stock is owned by hedge funds and other institutional investors.
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Articles
- Five stocks we like better than Plexus
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- The Biggest IPO Ever… Open to Everyday Folks
- Silver records prices are great. Monthly income is better
- Read this or regret it forever
- Sell this, buy that
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
